NI
XLRN

Numeric Investors’s Acceleron Pharma XLRN Stock Holding History

Numeric Investors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-17,500
Closed -$463K – 1208
2017
Q1 		$463K Buy
+17,500
New +$461K ﹤0.01% 810
2015
Q2 		– Sell
-13,900
Closed -$529K – 1124
2015
Q1 		$529K Buy
+13,900
New +$553K 0.01% 629
2014
Q4 		– Sell
-49,687
Closed -$1.5M – 1018
2014
Q3 		$1.5M Buy
49,687
+42,287
+571% +$1.19M 0.02% 369
2014
Q2 		$251K Buy
+7,400
New +$247K ﹤0.01% 688

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Numeric Investors's XLRN Position: Q2 2017 in Review

Numeric Investors sold out of Acceleron Pharma (XLRN) in Q2 2017, closing a stake of 17,500 shares — an estimated $463K sold.

Numeric Investors first reported a position in XLRN in Q2 2014 and held it in 4 quarters. The position peaked at $1.5M in Q3 2014. 128 funds tracked by Wall St. Rank hold XLRN as of Q2 2017.

  • Numeric Investors reported no remaining Acceleron Pharma position as of Q2 2017 after selling out during the quarter.
  • Numeric Investors sold 17,500 Acceleron Pharma shares in Q2 2017, an estimated $463K.
  • Numeric Investors first reported a position in Acceleron Pharma in Q2 2014 and held it in 4 quarters.
  • Numeric Investors's Acceleron Pharma position peaked at $1.5M in Q3 2014.
  • 128 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2017.

Based on Numeric Investors's 13F filing for Q2 2017, filed 14 Aug 2017.